Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AQST
Stock Latest News
The Fly
Aquestive Therapeutics assumed with an Outperform at Oppenheimer
10d ago
AQST
Premium
Market News
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
19d ago
AQST
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline
1M ago
AQST
Premium
Company Announcements
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
1M ago
8K
AQST
Premium
The Fly
Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA
1M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Announces Key Legal Leadership Transition
1M ago
8K
AQST
Premium
The Fly
Aquestive chief legal officer, chief compliance officer Lori Braender steps down
1M ago
AQST
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm
2M ago
AQST
Premium
Ratings
Reiterating Buy on Aquestive: Near-Term Cost Pressures Offset by Anaphylm-Driven 2027 Growth Potential and $10 Target
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch
2M ago
AQST
Premium
Company Announcements
AI Execution Risks Threaten Aquestive Therapeutics’ Competitiveness and Profitability
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics price target lowered to $9 from $12 at Alliance Global
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Amends RTW Deal, Strengthens Financing Outlook
2M ago
8K
AQST
Premium
The Fly
Aquestive Therapeutics reports Q4 adjusted EPS (15c), consensus (12c)
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics sees FY26 revenue $46M-$50M, consensus $47.52M
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics options imply 4.2% move in share price post-earnings
2M ago
AQST
Premium
Pre-Earnings
AQST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AQST
Premium
Company Announcements
Aquestive Highlights Strategy, Pipeline and Risk Disclosures
2M ago
8K
AQST
Premium
The Fly
Aquestive announces poster presentations on Anaphylm at AAAAI meeting
2M ago
AQST
Premium
Ratings
Aquestive Therapeutics: Strengthened Leadership and Regulatory Clarity Underpin Buy Rating on Anaphylm Opportunity
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics appoints Greenhawt as Chief Medical Officer
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics price target lowered to $6 from $8 at Lake Street
3M ago
AQST
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
